Literature DB >> 26348419

Monitoring: from cardiac output monitoring to echocardiography.

Mathieu Jozwiak1, Xavier Monnet, Jean-Louis Teboul.   

Abstract

PURPOSE OF REVIEW: Hemodynamic exploration is mandatory in patients with shock to identify the type of shock, to select the best therapeutic strategy, and to assess the efficacy of the selected therapy. In this review, we summarize the characteristics of the main available hemodynamic monitoring systems and emphasize on how to select the most appropriate ones in patients with circulatory shock. RECENT
FINDINGS: Over the past decade, hemodynamic monitoring techniques have progressively evolved from intermittent toward real-time measurements and from invasive toward less invasive approaches. Nowadays, echocardiography is recommended as the first-line modality of hemodynamic evaluation in patients with shock. Current guidelines recommend reserving advanced hemodynamic monitoring systems for patients not responding to the initial therapy and/or for complex conditions such as combination of shock with acute respiratory distress syndrome. Invasive and noninvasive uncalibrated cardiac output monitors, as well as esophageal Doppler, could find their place in the perioperative context rather than in patients with shock.
SUMMARY: The use of echocardiography should be encouraged at the initial period of shock to identify main involved mechanisms and to select the appropriate therapy. The use of more invasive monitoring systems should be discussed on an individualized basis.

Entities:  

Mesh:

Year:  2015        PMID: 26348419     DOI: 10.1097/MCC.0000000000000236

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  8 in total

1.  Less invasive hemodynamic monitoring in critically ill patients.

Authors:  Jean-Louis Teboul; Bernd Saugel; Maurizio Cecconi; Daniel De Backer; Christoph K Hofer; Xavier Monnet; Azriel Perel; Michael R Pinsky; Daniel A Reuter; Andrew Rhodes; Pierre Squara; Jean-Louis Vincent; Thomas W Scheeren
Journal:  Intensive Care Med       Date:  2016-05-07       Impact factor: 17.440

Review 2.  The crashing patient: hemodynamic collapse.

Authors:  Hitesh Gidwani; Hernando Gómez
Journal:  Curr Opin Crit Care       Date:  2017-12       Impact factor: 3.687

Review 3.  Advanced Hemodynamic Management in Patients with Septic Shock.

Authors:  Bernd Saugel; Wolfgang Huber; Axel Nierhaus; Stefan Kluge; Daniel A Reuter; Julia Y Wagner
Journal:  Biomed Res Int       Date:  2016-09-14       Impact factor: 3.411

4.  Transthoracic echocardiography: an accurate and precise method for estimating cardiac output in the critically ill patient.

Authors:  Pablo Mercado; Julien Maizel; Christophe Beyls; Dimitri Titeca-Beauport; Magalie Joris; Loay Kontar; Antoine Riviere; Olivier Bonef; Thierry Soupison; Christophe Tribouilloy; Bertrand de Cagny; Michel Slama
Journal:  Crit Care       Date:  2017-06-09       Impact factor: 9.097

Review 5.  Perfusion indices revisited.

Authors:  Ahmed Hasanin; Ahmed Mukhtar; Heba Nassar
Journal:  J Intensive Care       Date:  2017-03-14

Review 6.  Hemodynamic monitoring in patients with venoarterial extracorporeal membrane oxygenation.

Authors:  Ying Su; Kai Liu; Ji-Li Zheng; Xin Li; Du-Ming Zhu; Ying Zhang; Yi-Jie Zhang; Chun-Sheng Wang; Tian-Tian Shi; Zhe Luo; Guo-Wei Tu
Journal:  Ann Transl Med       Date:  2020-06

7.  Clinical examination, critical care ultrasonography and outcomes in the critically ill: cohort profile of the Simple Intensive Care Studies-I.

Authors:  Bart Hiemstra; Ruben J Eck; Geert Koster; Jørn Wetterslev; Anders Perner; Ville Pettilä; Harold Snieder; Yoran M Hummel; Renske Wiersema; Anne Marie G A de Smet; Frederik Keus; Iwan C C van der Horst
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

Review 8.  Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements.

Authors:  Marco Baldrighi; Pier P Sainaghi; Mattia Bellan; Ettore Bartoli; Luigi M Castello
Journal:  Curr Diabetes Rev       Date:  2018
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.